Acer Therapeutics (ACER) Insider Trading & Ownership → The new financial threat that could wipe out millions… (From InvestorPlace) (Ad) Free ACER Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipSocial Media Acer Therapeutics (NASDAQ:ACER) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage20.20%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$1.00 MNumber OfInsiders Selling(Last 3 Years)0 Get ACER Insider Trade Alerts Want to know when executives and insiders are buying or selling Acer Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ACER Insider Buying and Selling by Quarter Ad Behind the MarketsBREAKING – Pentagon to Spend $20 Billion on “Distributed AI”BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>> Acer Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/29/2022Chris SchellingCEOBuy819,672$1.22$999,999.84 12/9/2021Steve AselageDirectorBuy2,016$2.15$4,334.40 (Data available from 1/1/2013 forward) ACER Insider Trading Activity - Frequently Asked Questions Who is on Acer Therapeutics's Insider Roster? The list of insiders at Acer Therapeutics includes Chris Schelling, and Steve Aselage. Learn more on insiders at ACER. What percentage of Acer Therapeutics stock is owned by insiders? 20.20% of Acer Therapeutics stock is owned by insiders. Learn more on ACER's insider holdings. Which Acer Therapeutics insiders have been buying company stock? The following insider purchased ACER shares in the last 24 months: Chris Schelling ($999,999.84). How much insider buying is happening at Acer Therapeutics? Insiders have purchased a total of 819,672 ACER shares in the last 24 months for a total of $999,999.84 bought. More Insider Trading Tools from MarketBeat Related Companies: Cocrystal Pharma Insider Selling Tonix Pharmaceuticals Insider Selling Vaxxinity Insider Selling Aytu BioPharma Insider Selling VBI Vaccines Insider Selling Minerva Neurosciences Insider Selling Vincerx Pharma Insider Selling Indaptus Therapeutics Insider Selling Edesa Biotech Insider Selling Orgenesis Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:ACER) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acer Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.